Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06558604
Title A Phase II Study Evaluating Glofitamab in Combination With Venetoclax Plus Zanubrutinib or Venetoclax Alone in Subjects With Untreated or Relapsed/Refractory High-risk Mantle-cell Lymphoma (GLOASIS)
Acronym GLOASIS
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
Az Sint-Jan Brugge - Oostende Av Brugge Belgium Details
Institut Jules Bordet Brussel Belgium Details
Chu de Liege Liège Belgium Details
Chu Ucl Namur - Site Godinne Yvoir Belgium Details
Aphp - Hopital Henri Mondor Créteil France Details
Chu Dijon Bourgogne Dijon France Details
Chu de Lille - Hopital Claude Huriez Lille France Details
Institut Paoli Calmettes Marseille France Details
Chu de Montpellier Montpellier France Details
Chu de Nantes Nantes France Details
Chu Lyon-Sud Pierre-Bénite France Details
Chu de Reims - Hopital Robert Debre Reims France Details
Chu Pontchaillou Rennes France Details
Centre Henri Becquerel Rouen France Details
Institut Curie - Site Saint-Cloud Saint-Cloud France Details
Institut Curie Saint-Cloud France Details
Institut de Cancerologie Strasbourg Europe Strasbourg France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field